等待开盘 04-02 09:30:00 美东时间
0.000
0.00%
Ekso Bionics FY 2025 unrealized foreign exchange gain USD 1.97 million Ekso Bionics reported FY 2025 revenue of USD 12.8 million (-29%), with gross profit of USD 6.85 million (-28%) and gross margin of 53%. The company posted a FY 2025 operating loss of USD 13.33 million (+27%) and a net loss of USD
02-24 05:10
Ekso Bionics 10% Owner Daniel Asher Acquires Common Shares Daniel Asher, a 10% beneficial owner, reported an acquisition of 15,540 common shares of Ekso Bionics Holdings, Inc. The full filing can be accessed through the link below. Disclaimer: This news brief was created by Public Technologies (PUBT
02-21 05:58
BRIEF-Ekso Bionics Holdings On Feb 15, Enters Agreement With Apld Intermediate Feb 17 (Reuters) - Ekso Bionics Holdings Inc EKSO.O : EKSO BIONICS HOLDINGS - ON FEB 15, ENTERS AGREEMENT WITH APLD INTERMEDIATE - SEC FILING EKSO BIONICS HOLDINGS INC - TO RENAME AS CHRONOSCALE AFTER BUSINESS COMBINATIO
02-17 19:33
Applied Digital to Combine Cloud Unit with Ekso Bionics Applied Digital Corporation subsidiaries and Ekso Bionics Holdings have entered into an agreement under which Ekso will acquire Applied Digital Cloud Corporation. Following the completion of the deal, Cloud will become a wholly owned subsidiary
02-17 19:26
Ekso Bionics Announces Private Placement of Unregistered Shares Ekso Bionics Holdings Inc. has announced the issuance of shares in a private placement transaction as part of a Contribution and Exchange Agreement. The unregistered sale of equity securities will rely on an exemption from registration
02-17 19:12
Ekso Bionics Holdings Inc. Reports Initial Beneficial Ownership by Daniel Asher Ekso Bionics Holdings Inc. has filed an initial statement of beneficial ownership with the U.S. Securities and Exchange Commission. The filing identifies Daniel Asher as the beneficial owner. The full filing can be acces
02-06 07:21
EKSO BIONICS ( ($EKSO) ) has shared an update. On January 20, 2026, Ekso Bionic...
01-23 06:18
Ekso Bionics (EKSO) on Wednesday said it entered into securities purchase agreements on Jan. 20, 2026, with institutional and accredited investors for a private placement of 5,852 shares of Series B p...
01-21 22:06
Ekso Bionics Holdings announced on January 21, 2026, that it entered into securities purchase agreements with investors to sell 5,852 shares of Series B Preferred Stock and warrants for up to 355,960 common shares in a private placement. The Preferred Stock carries a stated value of $1,000 per share, convertible into 711,922 common shares at $8.22 each, with voting rights on an as-converted basis. Warrants are exercisable at $8.22 per share, expi...
01-21 13:30
Applied Digital is in advanced talks with an IG hyperscaler and plans to spin out its cloud compute segment.
01-09 22:03